Related Experiment Video
Updated: Oct 5, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency
M B Maessen-Visch1, K Hamulyak, D J Tazelaar
1Department of Dermatology, University Hospital Maastricht, The Netherlands.
Insights
The factor V Leiden mutation is more common in patients with venous leg ulcers and chronic venous insufficiency. This mutation increases the risk of deep vein thrombosis and recurrent leg ulcerations.
Area of Science:
- Vascular Medicine
- Genetics
- Dermatology
Background:
- Chronic venous insufficiency (CVI) and venous leg ulcers (VLUs) are significant clinical challenges.
- The role of genetic predispositions, such as factor V Leiden mutation, in the pathogenesis of CVI and VLUs requires further elucidation.
Purpose of the Study:
- To determine the prevalence of factor V Leiden mutation in patients with CVI and VLUs.
- To compare this prevalence against a control group.
- To investigate the association between factor V Leiden mutation and a history of deep venous thrombosis (DVT) in patients with CVI.
Main Methods:
- A case-control study was conducted across three outpatient dermatological clinics.
- Ninety-two patients diagnosed with venous leg ulcers were compared with 53 control patients.
- Factor V Leiden mutation was the primary outcome measure assessed.
Main Results:
- Factor V Leiden mutation was significantly more prevalent in patients with VLUs (23%) compared to controls (7.5%; P=.03).
- Patients with the mutation had a higher likelihood of a history of venous thromboembolism (91% vs 48%; P=.002).
- Recurrent DVT (38% vs 14%) and recurrent leg ulcerations (43% vs 19%) were more frequent in the factor V Leiden mutation group.
Conclusions:
- Factor V Leiden mutation is more frequent in individuals with venous leg ulceration than in the general population.
- The presence of factor V Leiden mutation is associated with an elevated risk of developing deep venous thrombosis and experiencing recurrent leg ulcerations.
Objectives:
To study the prevalence of factor V Leiden mutation in patients with chronic venous insufficiency and venous leg ulcers, compared with a control group, and to find out whether factor V Leiden mutation is more frequent in patients with chronic venous insufficiency and a history of deep venous thrombosis.
Design:
A case control study.
Setting:
Three outpatient dermatological clinics.
Patients:
Ninety-two patients (37 men, 55 women) with venous leg ulcers and 53 control patients (23 men, 30 women).
Main Outcome Measure:
Factor V Leiden mutation.
Results:
Factor V Leiden mutation was significantly more frequent in patients with chronic venous insufficiency and venous leg ulcers than in the control group (23% vs 7.5%; P=.03), and the patients with factor V Leiden mutation were more likely to have a history of venous thromboembolism (91% vs 48%, P=.002). Also, recurrent deep venous thrombosis (38% vs 14%) and recurrent leg ulcerations (9 episodes or more) occurred more frequently in the patients with factor V Leiden mutation (43% vs 19%, P=.01). No difference was observed in venous refill time or in the presence of dermatoliposclerosis and atrophie blanche.
Conclusions:
Factor V Leiden mutation is more frequent in patients with venous leg ulceration than in the control group and the general population. Patients with factor V Leiden mutation have an increased risk of developing deep venous thrombosis and recurrent leg ulceration.
More Related Videos
Related Concept Videos
Varicose Veins I: Introduction
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

